Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
Hiroki Ozawa, Rheumatologist at St.Luke’s International Hospital, shared a post on LinkedIn about a paper by Yuri Hiramatsu et al. published in Rheumatology:
“Real-World Data from Japan: Treat-to-Target Strategy in RA Pregnancy
Sharing new real-world evidence from the Japanese multicentre ANSWER cohort, which analyzed 118 pregnancies in women with rheumatoid arthritis (RA) and evaluated the impact of a treat-to-target (T2T) approach.
Key Insights from Japan
1․ T2T enables both disease control and healthy pregnancy outcomes
85% of patients maintained remission or low disease activity throughout pregnancy.
Tight control translated into excellent outcomes, including a 92.8% full-term delivery rate.
Continued use of pregnancy-compatible bDMARDs (e.g., etanercept, certolizumab pegol) was linked with lower disease activity during later trimesters.
2․ Salazosulfapyridine (SASP) shows a positive neonatal signal
Maternal SASP use in the third trimester was associated with higher birth weights (P=0.003) and a trend toward longer gestational ages (P=0.051).
While causality needs further confirmation, this real-world signal supports SASP as a potentially beneficial option during pregnancy.
Take-home message:
Individualized T2T strategies are feasible and effective in pregnant RA patients, supporting both maternal stability and optimal fetal health.
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study | Rheumatology | Oxford Academic
For more research summaries and clinical insights, I share quick audio digests here:
Journal Note — Spotify Podcast”
Title: Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study
Authors: Yuri Hiramatsu, Takuya Kotani, Eri Nakamura, Ayaka Yoshikawa, Motomu Hashimoto, Akira Onishi, Kouichi Murata, Natsuki Yamamoto, Kosaku Murakami, Toru Hirano, Yuichi Maeda, Kosuke Ebina, Sho Sendo, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Wataru Yamamoto, Tohru Takeuchi
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 4, 2026, 05:58Branimir Beljin: Before You Take Ashwagandha There’s One Question That Matters
-
Apr 4, 2026, 05:52Basheer Saeed: How the Immune System Influences Pregnancy Success and Risk
-
Apr 4, 2026, 05:50Sujatha Sagiraju: Proud to Be Part of a Team at Truveta Advancing Endometriosis Research
-
Apr 4, 2026, 05:45Somer Baburek: Endometriosis Enters a New Phase as Science and Awareness Converge
-
Apr 3, 2026, 12:57Sergei Gorlovetsky: The Invisible Work Breaking Fertility Clinics
-
Apr 3, 2026, 12:50Ting Yuan: Rethinking Oocyte Quality Through Reproducible Patterns
-
Apr 3, 2026, 12:36Asma Khalil: An Incredibly Powerful Podcast Brings Attention to Women’s Fertility Challenges
-
Apr 3, 2026, 12:29Angela Koech: Every 30 Seconds, Africa Loses a Baby to a Preventable Stillbirth
-
Apr 3, 2026, 12:17Sergei Gorlovetsky: AI Support Expands Guidance for IVF Patients at Home